Platelet Needs for Antiplatelet Therapy in Patients with Spontaneous Interacerebral hemorrhage - AABB PBM Column Newsletter

Carter BloodCare shares with you this October 2024 AABB PBM Column newsletter article written by Mark T. Friedman, DO at NYU Langone Health:

“Platelet concentrates are often transfused to patients receiving antiplatelet therapy who present with intracerebral hemorrhage (ICH). Yet, this practice remains controversial. While some data support the concept that platelet transfusion in patients with isolated ICH improves aspirin-induced platelet dysfunction, the European Guideline on Management of Major Bleeding and Coagulopathy Following Trauma (5th edition) supports platelet transfusion for patients with ICH only if surgical intervention is planned.1 At the same time, the results of recent studies have not found a clear benefit for platelet transfusion in patients with either traumatic or nontraumatic (i.e., spontaneous) ICH.1 This column will examine the evidence surrounding platelet transfusions for patients experiencing nontraumatic ICH while receiving antiplatelet medications.”